Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chubb
Covington
Federal Trade Commission
US Army
Merck
Farmers Insurance
Moodys
Queensland Health

Generated: April 22, 2018

DrugPatentWatch Database Preview

CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER Drug Profile

« Back to Dashboard

When do Cefotetan And Dextrose In Duplex Container patents expire, and when can generic versions of Cefotetan And Dextrose In Duplex Container launch?

Cefotetan And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER is cefotetan disodium. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
Summary for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
Drug patent expirations by year for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
Pharmacology for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
Medical Subject Heading (MeSH) Categories for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
Synonyms for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
(6R,7S)-4-((2-Carboxy-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)-1,3-dithietane-delta(sup 2,alpha)-malonamic acid, disodium salt
(6R,7S)-7-(4-(Carbamoylcarboxymethylene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, disodium salt
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethyl)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, (6R-cis)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, (6R-(6alpha,7al
69712-56-7 (Parent)
74356-00-6
AC1L1E30
AKOS025311215
AN-37204
Apatef
C14007
C17H15N7O8S4.2Na
C17H17N7O8S4.2Na
Cefotan
Cefotan (TN)
CEFOTAN IN PLASTIC CONTAINER
CEFOTETAN DISODIUM
Cefotetan disodium (USP)
Cefotetan disodium [USAN:USP]
Cefotetan disodium [USAN]
Cefotetan disodium salt
Cefotetan disodium, Antibiotic for Culture Media Use Only
cefotetan sodium
Cefotetan sodium (JAN)
Ceftenon
Cepan
CHEBI:34617
CHEMBL1201098
D02228
Darvilen
disodium (6R,7S)-7-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium (6R,7S)-7-[[4-(1-amino-3-oxido-1,3-dioxopropan-2-ylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium (6R,7S)-7-[[4-(2-amino-1-carboxylato-2-oxo-ethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Disodium (7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium 7beta-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylate
Disodium(7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
EINECS 277-834-9
FT-0645368
HE385221
ICI 156834 disodium
ICI-156834
LS-149943
M153
PubChem19005
SCHEMBL40794
UNII-0GXP746VXB
Yamatetan
YM 09330
YM-09330

US Patents and Regulatory Information for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER cefotetan disodium INJECTABLE;INJECTION 065430-001 Aug 9, 2007 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
B Braun CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER cefotetan disodium INJECTABLE;INJECTION 065430-002 Aug 9, 2007 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Medtronic
Daiichi Sankyo
Moodys
Merck
US Army
Express Scripts
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.